# Biocryst Pharmaceuticals Inc: Form 8-K, filed Feb 24, 2025

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K
- Filed: 2025-02-24
- Accepted by EDGAR: Feb 24, 2025, 07:06 ET
- Period: 2025-02-24
- Accession: 0001171843-25-001020
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184325001020/f8k_022425.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184325001020/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184325001020/f8k_022425.htm

Filed Feb 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-001020. Last ingested by Listed: Nov 4, 2026, 07:31 ET. No prices; not investment advice.